دورية أكاديمية

Central composite design driven optimization of sustainable stability indicating HPLC method for the determination of Tigecycline and greenness assessment.

التفاصيل البيبلوغرافية
العنوان: Central composite design driven optimization of sustainable stability indicating HPLC method for the determination of Tigecycline and greenness assessment.
المؤلفون: Hafez HM; Pharmaceutical Chemistry Department, College of Pharmacy, Al-Esraa University, Baghdad, 10045, Iraq., Barghash SS; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt., Soliman MM; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt., Soltan MK; Pharmacy Department, Oman College of health sciences, Muscat, Muscat, Oman.; Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Sharqia, Egypt., Abd Elrahman M; Department of Pharmacy, Al-Mustaqbal University College, Babylon, Iraq., Katamesh NS; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
المصدر: F1000Research [F1000Res] 2023 Aug 10; Vol. 12, pp. 341. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: F1000 Research Ltd Country of Publication: England NLM ID: 101594320 Publication Model: eCollection Cited Medium: Internet ISSN: 2046-1402 (Electronic) Linking ISSN: 20461402 NLM ISO Abbreviation: F1000Res Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : F1000 Research Ltd
مواضيع طبية MeSH: Anti-Bacterial Agents* , Ethanol*, Tigecycline ; Chromatography, High Pressure Liquid/methods ; Water
مستخلص: Background: Tigecycline (TGC) is a recently developed antibiotic to battle resistant bacteria. The procedures outlined in the literature for analyzing TGC involve chemical solvents that could be hazardous. Therefore, this study aimed to create a sustainable and stable HPLC technique for quantifying Tigecycline in lyophilized powder. The powerful chemometric tool, experimental design (ED), will be applied to analyze the variables' interaction and impact on the selected analytical target profiles. Response surface methodology provides a tutorial on using the central composite design with three levels of variables and quadratic programming to optimize the design space of the developed method. Methods: The New HPLC method consisted of an aqueous buffer and ethanol as a green mobile phase run on a reversed-phase symmetry C18 column. A full resolution between the Tigecycline and its degradation product peaks was achieved in a short analytical runtime. Results: Further, the specificity, accuracy, precision, robustness and stability indicating power of the proposed approach were verified through stress degrading testing. Conclusions: Finally, the analytical eco-scale and the green Analytical Procedure Index (GAPI) were utilized to determine how environmentally friendly the recommended method was compared to other published approaches.
Competing Interests: No competing interests were disclosed.
(Copyright: © 2023 Hafez HM et al.)
References: Biomed Chromatogr. 2016 Dec;30(12):1992-2002. (PMID: 27245381)
J Chromatogr Sci. 2013 Feb;51(2):192-9. (PMID: 22832547)
Bioanalysis. 2010 Jan;2(1):81-94. (PMID: 21083122)
J AOAC Int. 2011 May-Jun;94(3):847-56. (PMID: 21797013)
J Antimicrob Chemother. 2014 Oct;69(10):2606-10. (PMID: 24879669)
Ther Drug Monit. 2010 Jun;32(3):282-8. (PMID: 20431506)
Biomed Chromatogr. 2018 Feb;32(2):. (PMID: 28677837)
Talanta. 2018 May 1;181:204-209. (PMID: 29426502)
Curr Opin Pharmacol. 2001 Oct;1(5):464-9. (PMID: 11764771)
Molecules. 2015 Jun 12;20(6):10928-46. (PMID: 26076112)
J Exp Clin Cancer Res. 2017 Mar 10;36(1):43. (PMID: 28283035)
Front Microbiol. 2021 Jun 16;12:678165. (PMID: 34220762)
PLoS One. 2014 May 28;9(5):e95281. (PMID: 24871339)
Crit Care. 2018 Dec 17;22(1):341. (PMID: 30558639)
Int J Anal Chem. 2020 Dec 29;2020:6671392. (PMID: 33456470)
Chem Rev. 2007 Jun;107(6):2695-708. (PMID: 17521200)
Clin Ther. 2006 Aug;28(8):1079-1106. (PMID: 16982286)
Rapid Commun Mass Spectrom. 2021 Jul 31;35(14):e9112. (PMID: 33913212)
Ther Drug Monit. 2013 Dec;35(6):853-8. (PMID: 24067259)
J Sep Sci. 2014 Jun;37(12):1396-403. (PMID: 24659422)
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Nov 25;811(2):225-9. (PMID: 15522724)
Perit Dial Int. 2016 Jul-Aug;36(4):410-4. (PMID: 26526051)
Biomed Chromatogr. 2016 Jun;30(6):837-45. (PMID: 26378888)
J Sep Sci. 2015 Oct;38(19):3354-62. (PMID: 26235225)
فهرسة مساهمة: Keywords: Tigecycline; Green liquid chromatography; GAPI; Stability indicating; HPLC; experimental design
سلسلة جزيئية: figshare 10.6084/m9.figshare.22153613.v1
المشرفين على المادة: 70JE2N95KR (Tigecycline)
0 (Anti-Bacterial Agents)
3K9958V90M (Ethanol)
059QF0KO0R (Water)
تواريخ الأحداث: Date Created: 20230818 Date Completed: 20231004 Latest Revision: 20231004
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10427804
DOI: 10.12688/f1000research.130861.2
PMID: 37593362
قاعدة البيانات: MEDLINE
الوصف
تدمد:2046-1402
DOI:10.12688/f1000research.130861.2